Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers

Clinical Nephrology

Volumn 61, Issue 3, 2004, Pages 198-206

  Walker, Rob J ^a,b   Sutherland, W H F ^a   De Jong, S A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Biocompatibility; Cell adhesion molecules; Cellulose; Cytokines; Hemodialysis; Inflammation; Polysulphone; Protein oxidation

Indexed keywords

BETA 2 MICROGLOBULIN; CELL ADHESION MOLECULE; CELLULOSE ACETATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOFUSCIN; POLYSULFONE; PROTEIN; THIOL; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; FLUORESCENCE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MALE; OXIDATION; OXIDATIVE STRESS;

EID: 1642321057     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP61198     Document Type: Article

References (28)

1. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A 1998 Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79: 399-407
2. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA 2002 Inflammatory signals associated with hemodialysis. Kidney Int 62: 1408-1416
3. Charra B, Calemaard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G 1992 Survival as an index of adequacy of dialysis. Kidney Int 41: 1286-1291
4. Cybulsky MI, Iiyama K, Li H, Zhu SN, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS 2001 A major role for VCAM-1 but not ICAM-1, in early atherosclerosis. J Clin Invest 107: 1255-1262
5. Dantoine TF, Debord J, Charmes J-P, Merle L, Marquet P, Lachatre G, Leroux-Robert C 1998 Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9: 2082-2088
6. Descamp-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P, Dayer J-M 1995 Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 154: 882-892
7. Girndt M, Heisel O, Köhler H 1999 Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol Dial Transplant 14: 676-682
8. Hakim RM, Breillatt J, Lazarus JM, Port FK 1984 Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311: 878-882
9. Hakim RM, Held P, Stannard D, Wolfe RA, Port FK, Daugirdas JT, Agodoa L 1996a Effect of dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50: 566-570
10. 2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol 7: 472-478
11. Himmelfarb J, McMonagle E, McMenamin E 2000 Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58: 2571-2578
12. Jackson P, Loughrey CM, Lighthody JH, McNamee P, Young IS 1995 Effect of haemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41: 1135-1138
13. 2-microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts. Kidney Int 59: 1951-1959
14. Koster JF, Biemond P, Swaak AJG 1986 Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis 45: 44-46
15. Linder A, Charra B, Sherrard DJ, Scribner BH 1974 Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 698-701
16. Lonneman G 2000 The quality of dialysate: An integrated approach. Kidney Int 58 (Suppl 76): S-112-S-119
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
18. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA 1996 Paraoxonase biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7: 69-76
19. Pertosa G, Grandaliano G, Gesualdo L, Schena FP 2000 Clinical relevance of cytokine production in hemodialysis. Kidney Int 58 (Suppl 76): S104-S111
20. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D 1995 Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96: 1395-1403
21. Sebeková K, Podracká L, Blazícek P, Syrová D, Heidland A, Schinzel R 2001 Plasma levels of advanced glycation end products in children with renal disease. Pediatr Nephrol 16: 1105-1112
22. Sutherland WHF, Walker RJ, De Jong SA, Van Rij AM, Phillips V, Walker HL 1999 Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 19: 1340-1347
23. Tsuchida M, Miura T, Mizutani K, Aibara K 1985 Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation. Biochim Biophys Acta 834: 196-204
24. 2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem 28: 1379-1388
25. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B 1996 Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313
26. Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer J-M, Jungers P, Drüeke T, Descamps-Latscha B 1998 Advanced oxidation protein products and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532
27. Yin D 1996 Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 21: 871-888
28. 2-microglobulin production and cellular expression. Kidney Int 38: 962-968